Search Results - "Giroux, B."

Bone and joint involvement in Fabry disease by Sacre, K, Lidove, O, Leprieur, B Giroux, Ouali, N, Laganier, J, Caillaud, C, Papo, T

“…Abstract Fabry disease (FD) is an X-linked lysosomal storage disease caused by deficient activity of the enzyme α-galactosidase A. Although the disease has…”
Get full text

Phase I and pharmacokinetic study of the association of capecitabine–cisplatin in head and neck cancer patients by Pivot, X., Chamorey, E., Guardiola, E., Magné, N., Thyss, A., Otto, J., Giroux, B., Mouri, Z., Schneider, M., Milano, G.

“…The combination of cisplatin and 5-fluorouracil (5-FU) is considered to be the standard treatment in induction chemotherapy for patients with squamous cell…”
Get full text

Performance of convolutional perfectly matched layers for pseudospectral time domain poroviscoelastic schemes by Giroux, Bernard

“…This paper presents an implementation of the convolutional perfectly matched layer for the velocity–stress formulation of poroviscoelastic equations in…”
Get full text

Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules by Awada, A., Giacchetti, S., Gerard, B., Eftekhary, P., Lucas, C., de Valeriola, D., Poullain, M. G., Soudon, J., Dosquet, C., Brillanceau, M.-H., Giroux, B., Marty, M., Bleiberg, H., Calvo, F., Piccart, M.

“…S 16020, a new 9-OH olivacine derivative, is a novel topoisomerase II inhibitor with activity in cell lines presenting the classical multidrug resistance…”
Get full text

Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer by Pivot, X., Awada, A., Gedouin, D., Kerger, J., Rolland, F., Cupissol, D., Caponigro, F., Comella, G., Lopez-Pousa, J. J., Guardiola, E., Giroux, B., Gérard, B., Schneider, M.

“…Background: The purpose of this study was to carry out two randomised phase II trials of S16020, a new olivacine derivative, tested as a single agent in…”
Get full text

Vitamine K antagonists overdose: Physician adherence to the French guidelines by Oliosi, E, Pointeau, O, Mazoyer, E, Le Jeune, S, Giroux-Leprieur, B, Dhôte, R, Mourad, J J

“…Vitamin K antagonists (VKA) are drugs with a major risk of side effect. Guidelines have been published in 2008 by the Haute Autorité de santé (HAS) concerning…”
Get full text

Usefulness of different techniques of blood pressure measurements in 2016 by Le Jeune, S, Pointeau, O, Hube, C, Lopez-Sublet, M, Giroux-Leprieur, B, Dhote, R, Mourad, J-J

“…The management of hypertensive patients is greatly influenced by blood pressure levels and accurate measurement of blood pressure is crucial in this context…”
Get full text

P.91Optimization of AAV-mediated gene therapy for SOD1-linked ALS by Biferi, M., Cohen-Tannoudji, M., Marais, T., Giroux, B., Astord, S.

Get full text

HEREDITARY NEUROPATHIES & ALS by Elouej, S., Delamare, M., Cappella, M., Cohen-Tannoudji, M., Astord, S., Marais, T., Giroux, B., Pezet, S., Biferi, M.

Get full text

HEREDITARY NEUROPATHIES & ALS: P.115 Analysis of off-target effects of antisense sequence inducing exon skipping in SOD1-linked amyotrophic lateral sclerosis by Elouej, S., Delamare, M., Cappella, M., Cohen-Tannoudji, M., Astord, S., Marais, T., Giroux, B., Pezet, S., Biferi, M.

Get full text

Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial by Stupp, R., Bauer, J., Pagani, O., Gerard, B., Cerny, T., Sessa, C., Bastian, G., Sarkany, M., Schläpfer, J., Giroux, B., Leyvraz, S.

“…Background: S9788 is a triazineaminopiperidine derivative capable of reversing multidrug resistance (MDR) in vitro. In preclinical models S9788 was several…”
Get full text

A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer by Cotto, C., Berille, J., Souquet, P.J., Riou, R., Croisile, B., Turjman, F., Giroux, B., Brune, J., Trillet-Lenoir, V.

“…A phase II study was conducted in order to determine the feasibility and toxicity of cisplatin combined with the nitrosourea fotemustine in central nervous…”
Get full text

Phase II study of fotemustine in recurrent supratentorial malignant gliomas by Frenay, M, Giroux, B, Khoury, S, Derlon, J M, Namer, M

“…38 adults with recurrent supratentorial malignant gliomas, including glioblastoma multiforme (21), anaplastic astrocytomas (9), probably transformed low-grade…”
Get more information

Comparisons between surface electrodes and intramuscular wire electrodes in isometric and dynamic conditions by Giroux, B, Lamontagne, M

“…The purpose of this study was to compare EMG surface electrodes (SE) and intramuscular wire electrodes (IWE) for isometric and dynamic contractions during an…”
Get more information

TH.O.16 - A new AAV10-mediated gene therapy for SOD1-linked ALS by Biferi, M., Cohen-Tannoudji, M., Cappelletto, A., Giroux, B., Roda, M., Astord, S., Marais, T., Ferry, A., Voit, T., Barkats, M.

Get full text

A new AAV10-mediated gene therapy for SOD1 -linked ALS by Biferi, M., Cohen-Tannoudji, M., Cappelletto, A., Giroux, B., Roda, M., Astord, S., Marais, T., Ferry, A., Voit, T., Barkats, M.

Get full text

Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastases by Hartmann, J.T, Schmoll, E, Bokemeyer, C, Fety, R, Lucas, C, Giroux, B, Schmoll, H.-J

“…Fotemustine was investigated in 17 patients with progressive hepatic metastases from colorectal carcinoma to define the maximally tolerated dose for a daily…”
Get full text

Time-schedule dependency of S 16020, a new topoisomerase II inhibitor by Soudon, J, Milano, G, Poullain, M G, Fischel, J L, Formento, P, Berlion, M, Giroux, B

“…S 16020 is a new olivacine derivative which has been shown to intercalate into DNA and to stabilize the cleavable complex formed by DNA and purified…”
Get more information

New ABCC8 Mutations in Relapsing Neonatal Diabetes and Clinical Features by VAXILLAIRE, Martine, DECHAUME, Aurélie, BUSIAH, Kanetee, CAVE, Hélène, PEREIRA, Sabrina, SCHARFMANN, Raphael, PEREZ DE NANCLARES, Guiomar, CASTANO, Luis, FROGUEL, Philippe, POLAK, Michel

“…New ABCC8 Mutations in Relapsing Neonatal Diabetes and Clinical Features Martine Vaxillaire 1 , Aurélie Dechaume 1 , Kanetee Busiah 2 3 , Hélène Cavé 4 ,…”
Get full text

Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients by Rixe, O, Borel, C, Paraiso, D, Benhammouda, A, Petit, T, Antoine, E, Bizzari, J P, Auclerc, G, Soubrane, C, Weil, M

“…Fotemustine and dacarbazine constitute the most active single chemotherapeutic agents in the treatment of melanoma. In this phase II study we evaluated the…”
Get more information